News and thought leadership
Subscribe to our latest updates, reports and upcoming events. Subscribe >
Showing 1 - 10 of 215
Imminent changes to Qualified One-Way Cost Shifting: levelling the playing field
The UK Government has published its response to its consultation on changes to the Qualified One-Way Cost Shifting (QOCS) regime in personal injury cases, which was launched on 9 May 2022.
In Practice Series - The future Medical Device Regulations within the UK
On 26 June 2022, the UK’s medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) published their response to the consultation on the “future regulation of medical devices in the UK”, which indicates future wide-reaching change for the UK medical devices regulatory regime going forward.
Commercial Brief innovation market insights - March 2023
As Kennedys launches its campaign on fostering innovation, we share our insights on the impact of artificial intelligence (AI) in the workplace, regulating AI in the life sciences sector and the novel risks inherent in modern technologies.
UK product safety update: two year extension given to businesses for GB specific product safety marking
The UK Government announced on 14 November 2022 that businesses would be given a further two years to apply the new UK Conformity Assessed (UKCA) product safety marking to their products. The UKCA mark is the UK equivalent of the European Union’s CE mark, which denotes compliance with mandatory applicable product regulations when applied to products.
Insurers face increased risk from evolving product safety laws
The EU's proposed General Product Safety Regulations aim to bring product safety regulation into the modern age but will introduce a more onerous and broader range of compliance obligations on insured businesses.
In Practice Series – How to prepare for the European Medical Devices and In Vitro Diagnostic Regulations
On 6 January 2023, the EU Commission published its draft legislative proposal to amend the transitional provisions in Regulation (EU) 2017/745 for medical devices (MDR) and Regulation (EU) 2017/746 (IVDR) for in vitro diagnostic medical devices.
Insurance forecast 2023: claims trends and future risks
Drawing on our experience across various risks, this 2023 insurance forecast report highlights some of the key trends that we anticipate will shape the insurance agenda for 2023 and beyond.
Intangible risks of modern products
In this blog, we explore how developments in technology have created new types of product liability and safety risks and given rise to new categories of damage. We also examine developments in the mechanisms for claiming damages.
In Practice Series – How to prepare for the upgraded digital services laws in Europe
It is undeniable that the way consumers purchase their products and engage with services on the internet has changed substantially since times past. The modern consumer has global buying power, and suppliers must adapt in order to meet this consumer demand. This change in consumer behaviour has brought both benefits, but also introduced legal risks that have required careful consideration by regulators and legislators alike.
In Practice Series – How to mitigate the growing risk from consumer class actions and Collective Redress in Europe
In the last ten years there has been a significant growth in the use of collective redress or representative actions ('group litigation'), a legal mechanism which may stop or prevent unlawful business practices that affect multiple claimants or compensate them for harm caused by these practices, within the EU and UK.